Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diffuse Sclerosis Systemic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06925542
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Who this might be right for
SLE (Systemic Lupus)Lupus Erythematosus, SystemicLupus Nephritis+4 more
CRISPR Therapeutics 80
Not applicableStudy completedNCT06095921
What this trial is testing

The Effect of a Self-Management Program on Individuals With Scleroderma

Who this might be right for
SclerodermaSystemic Sclerosis
Emirhan Karakuş 29
Not applicableLooking for participantsNCT01656447
What this trial is testing

Scleroderma Registry & Repository at the Hospital for Special Surgery

Who this might be right for
Scleroderma
Hospital for Special Surgery, New York 300
Early research (Phase 1)Study completedNCT00433186
What this trial is testing

Mycophenolate Mofetil in Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Boston University 30
Not applicableStudy completedNCT00001330
What this trial is testing

Study of Silicone-Associated Connective Tissue Diseases

Who this might be right for
Autoimmune DiseasesConnective Tissue DiseasesScleroderma, Circumscribed+1 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 60
Early research (Phase 1)Study completedNCT00848939
What this trial is testing

Pharmacokinetics of Oral Treprostinil in Patients With Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
United Therapeutics 28
Testing effectiveness (Phase 2)Study completedNCT02161406
What this trial is testing

Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Dinesh Khanna, MD, MS 88
Testing effectiveness (Phase 2)Study completedNCT01393132
What this trial is testing

Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye

Who this might be right for
Dry EyeSjogren's SyndromeGraft vs. Host Disease
Michigan Cornea Consultants, PC 9
Testing effectiveness (Phase 2)WithdrawnNCT04138485
What this trial is testing

Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc)

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
CSL Behring
Early research (Phase 1)Ended earlyNCT00418132
What this trial is testing

Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis

Who this might be right for
Scleroderma, Systemic
NYU Langone Health 30
Not applicableStudy completedNCT02835196
What this trial is testing

Optical Elastography of Systemic Sclerosis Skin

Who this might be right for
Scleroderma
The University of Texas Health Science Center, Houston 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04986605
What this trial is testing

Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 15
Not applicableUnknownNCT03560154
What this trial is testing

Effects of Whole Body Vibration Training in Patients With Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseSclerodermaIdiopathic Pulmonary Fibrosis
Istanbul University 60
Large-scale testing (Phase 3)Study completedNCT02896205
What this trial is testing

Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung Disease

Who this might be right for
Systemic SclerosisSclerodermaInterstitial Lung Disease
Post Graduate Institute of Medical Education and Research, Chandigarh 41
Not applicableLooking for participantsNCT04917705
What this trial is testing

Search for Diagnostic and Prognostic Biomarkers in Systemic Sclerosis and Inflammatory Myopathies

Who this might be right for
Systemic SclerosisInflammatory Myopathies
University Hospital, Strasbourg, France 55
Testing effectiveness (Phase 2)WithdrawnNCT02166229
What this trial is testing

Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma

Who this might be right for
SclerodermaSystemic Sclerosis
Yale University
Not applicableLooking for participantsNCT07090226
What this trial is testing

Diffuse Cutaneous Scleroderma (DSSc) SFDI Study

Who this might be right for
Systemic SclerodermaDiffuse Cutaneous Scleroderma
Boston University 65
Not applicableLooking for participantsNCT06598982
What this trial is testing

Investigation of Respiratory Muscle Sarcopenia in Patients With Systemic Sclerosis

Who this might be right for
Systemic Sclerosis (SSc)Scleroderma
Selcuk University 85
Testing effectiveness (Phase 2)Ended earlyNCT06400303
What this trial is testing

KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis

Who this might be right for
Systemic SclerosisSystemic Sclerosis - Diffuse CutaneousSystemic Sclerosis - 2013 ACR/EULAR Classification Criteria
Kyverna Therapeutics 3
Testing effectiveness (Phase 2)Study completedNCT04647890
What this trial is testing

Effects of FT011 in Systemic Sclerosis

Who this might be right for
Scleroderma, SystemicScleroderma, DiffuseSclerosis, Systemic
Certa Therapeutics 30
Next Page